Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock by Ye, Rui et al.
Biochemical Analysis of the Canonical Model for the
Mammalian Circadian Clock*□S
Received for publication, April 25, 2011, and in revised form, May 20, 2011 Published, JBC Papers in Press, May 25, 2011, DOI 10.1074/jbc.M111.254680
Rui Ye, Christopher P. Selby, Nuri Ozturk, Yunus Annayev, and Aziz Sancar1
From the Department of Biochemistry and Biophysics, University of North Carolina School of Medicine,
Chapel Hill, North Carolina 27599
The current consensusmodel for the circadian clock inmam-
mals is based on a transcription-translation feedback loop. In
this model, CRY and PER proteins repress their own transcrip-
tion by suppressing the transactivator function of the CLOCK:
BMAL1 heterodimer directly (physical model) and by facilitat-
ing post-translational modifications (chemical model). Most of
the data for this model come from genetic and cell biological
experiments. Here, we have purified all of the core clock pro-
teins and performed in vitro and in vivo biochemical experi-
ments to test the physical model. We find that CLOCK:BMAL1
binds to anE-box sequence inDNAand thatCRYbinds stably to
the CLOCK:BMAL1:E-box ternary complex independently of
PER. Both CRY and PER bind to CLOCK and BMAL1 off DNA
but, in contrast to CRY, PER does not bind to the CLOCK:
BMAL1:E-box complex. Unexpectedly, PER actually interferes
with the binding of CRY to the CLOCK:BMAL1:E-box ternary
complex. CRY likely destabilizes the CLOCK:BMAL1 het-
erodimer on DNA by a post-translational mechanism after
binding to the complex. These findings support some aspects of
the canonical model, but also suggest that some key features of
the model need to be revised.
The circadian clock is the internal timekeeping system that
generates a daily rhythm in physiology and behavior of an orga-
nism (1–3). In mice and humans this rhythmic behavior is gen-
erated by amolecular clock with a periodicity of about 24 h that
consists of a transcription-translation feedback loop (TTFL).2
The core mammalian molecular clock is made up of 4 genes/
proteins and their paralogs: Clock (Npas2), Bmal1, Cry (Cry1
and Cry2), and Per (Per1 and Per2), and according to the cur-
rent consensus model, operates as follows: the BMAL1 and
CLOCKproteins, which aremembers of the bHLH (basic helix-
loop-helix) family of transcription factors, make a heterodimer,
which binds to the E-box element in the promoters of Per and
Cry genes and activates their transcription (positive arm). The
CRY and PER proteins make heterodimeric complexes, which,
after a time lag enter the nucleus and inhibit the CLOCK:
BMAL1-activated transcription of their own genes (negative
arm). This core circuitry is consolidated by additional inter-
locking transcriptional circuits as well as post-translational
modifications and proteolytic degradation of the core clock
proteins (1, 3, 4).
The TTFL model is largely based on genetic data from mice
with mutations in the so-called core clock genes, on protein-
protein interaction data, reporter gene assays, and ChIP analy-
sis (5–10). Various studies have led to several models for how
CRY and PER repress their own transcription as well as the
transcription of output genes controlled by the transactivation
function of CLOCK:BMAL1. These, not necessarily mutually
exclusive models, include: 1) physical (steric) models and 2)
chemical (catalytic) models. In the steric model, binding of
CRY, PER, or the PER:CRY complex to CLOCK and BMAL1
interferes with their transcription function (10). In the catalytic
model, the “repressor” is actually a protein that recruits
enzymes for post-translational modification of the activator
complex and eventualy changes its activity (11–13). There are
numerous versions of both the chemical and physical models,
and quite likely both mechanisms contribute to the generation
of robust circadian rhythmicity at the transcriptional level.
Here we have used a biochemical approach to investigate the
mechanisms by which the two proteins in the negative arm of
themammalian TTFLmodel, CRY and PER,may interfere with
the transactivator function of CLOCK and BMAL1. Specifi-
cally, we have addressed the following questions: (a) do CRY or
PER interfere with the formation of the CLOCK:BMAL1 com-
plex as has been suggested for zebrafish CRY1a (14) or do they
inhibit CLOCK:BMAL1 from binding to its target sequence by
shifting the equilibrium to the unbound form as has been
suggested for Drosophila PER (15, 16); (b) do both CRY and
PER interact with CLOCK and BMAL1 on and off DNA; (c)
during repression of CLOCK-BMAL1, does PER bring CRY to
the CLOCK:BMAL1:E-box complex (17) or is it the other
way around?We find that both CRY and PER bind to CLOCK-
BMAL1 off DNA. Unexpectedly, and not predicted by any of
the current models, only CRY binds to the CLOCK:BMAL1:
DNA ternary complex. Neither the PER:CRY heterodimer nor
PER alone can bind to CLOCK:BMAL1:DNA and, in fact, at a
sufficiently high concentration PER interferes with the binding
of CRY to this complex. These in vitro data were supported by
ChIP analysis with various mouse clock gene knock-out cell
lines, which revealed that binding of CRY to the cognate pro-
moters is dependent on BMAL1 but independent of PER. In
light of these findings we propose a revised TTFLmodel for the
mammalian circadian clock.
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EXPERIMENTAL PROCEDURES
Cells and Antibodies—The Cry1/ Cry2/ mouse skin
fibroblasts have been described previously (18). The isogenic
Bmal1/ and Bma1/ and Clock/ and Clock/ mouse
embryonic fibroblast cell lines (19) were kindly provided by Dr.
Marina Antoch (Roswell Park Cancer Institute). The Per1/
Per2/ skin fibroblasts were prepared from a male double
knock-out mouse (20) kindly provided by Dr. Cheng Chi Lee
(University of Texas, HoustonMedical School). Mouse embry-
onic fibroblasts expressing mCry1-FLAG and mPer2-FLAG
were made by retrovirus infection. Briefly, mCry1-Flag-
pBABEpuro and mPer2-Flag-pBABEpuro constructs were
made and co-transfected together with pVSVG and pCIHPZ
into HEK293T to produce retrovirus particles. Then mouse
embryonic fibroblast cells were infectedwith the retrovirus and
transfectants were selected in medium containing puromycin
for 2 weeks. Single colonies were picked and cultured for sub-
sequent analysis.
Anti-mCRY1 (IgM type monoclonal) and anti-CRY2 anti-
bodies were described previously (18, 21). Anti-CLOCK and
anti-BMAL1 antibodies were purchased from Santa Cruz and
Bethyl Laboratories. Rabbit anti-PER2 antibodies were gener-
ated by using theN-terminal 200 amino acids ofmPER2protein
as immunogen as described previously (22) and immunopuri-
fied by antigen that was covalently coupled to AminoLink resin
(Pierce). Anti-Myc(9E10), anti-V5, anti-FLAG, and anti-His
antibodies were purchased from Santa Cruz, Invitrogen, Sigma,
and Abgent, respectively.
Plasmids—Plasmids used in this work were obtained from
Addgene. Detailed construct cloning information is described
under supplemental “Methods”. The hCry1-His baculovirus
construct was described previously (23).
Clock Proteins—Proteins were purified either from baculovi-
rus-infected Sf21 insect cells or from transfected HEK293T
cells. Most of the proteins used in our experiments were puri-
fied with the baculovirus system, except Myc-CRY1 and Myc-
CRY2, which were purified from the mammalian expression
system. Proteins purified using the two systems showed similar
properties. Detailed purification procedures are described
under supplemental “Methods”. MAX (MYC-associated factor
X) protein used in some gelmobility shift assays as a controlwas
purchased from ProteinOne, USA.DrosophilaCRY was gener-
ated as described elsewhere (24).
Electrophoretic Mobility Shift Assay—Two DNA duplexes
were used as DNA binding substrates: a 14-bp duplex “M34”
(25) and a 60-bp duplex “P2GS.” Sequences of these oligos are
listed in supplemental Table S1. To prepare radiolabeled
probes, 40 pmol of M34TOP or P2GSA were labeled with
[-32P]ATP using polynucleotide kinase (New England Bio-
labs). DNA was then extracted with phenol/chloroform, and
the labeled oligonucleotides were annealed with complemen-
tary strands (M34BTM and P2GS). Mini-quick spin oligo col-
umns (Roche Applied Science) were used to remove the free
ATP from labeled DNA. In EMSA experiments, the binding
buffer consisted of 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 1 mM
EDTA, 6 mM dithiothreitol, and 20 g/ml of poly(dI-dC)
(Sigma). Radiolabeled DNA at 1 nM was mixed in 15 l with
clock proteins in the following order depending on the experi-
ments: 1) CLOCK:BMAL1 for 10min, 2) CLOCK:BMAL1 for 5
min, then CRY, PER, or hCRY1:PER2 protein for 8 min, or 3)
CLOCK:BMAL1 for 5 min, then CRY for 8 min, and PER for 8
min. All reactionswere incubated at 22 °C followed by 10min at
4 °C. In antibody supershift experiments, about 1 g of anti-
body was added for an additional 5 min after the original incu-
bation at 22 °C. The reactions were loaded onto 4% nondena-
turing polyacrylamide gels, and productswere resolved at 100V
for 3 h at 4 °C. We note that under these reaction conditions
CRY in isolation does not exhibit anyDNAbinding activity (Fig.
1D). Gels were dried and exposed to x-ray film.
DNase I Footprinting—Protein/DNA mixtures were pre-
pared as in the electrophoretic mobility shift assay using P2GS
DNA. Reactions, in addition toDNA, included: 1) no protein, 2)
BMAL1:CLOCK (0.2 nM) alone, or 3) CLOCK:BMAL1 (0.2 nM)
plus an amount of CRY (1 nM) that binds all of the CLOCK:
BMAL1:E-box complexes as determined by gel shift analysis.
Reactions in 15 l were incubated at 22 °C for 20min. Then 0.5
units of DNase I (Promega) andMgSO4 (10 mM), CaCl2 (1 mM)
were added to each reaction, and after 5 min at 22 °C, digestion
was stopped by adding EDTA to 25 mM. Then the reactions
were loaded onto a 4% nondenaturing polyacrylamide gel to
separate protein-bound and free DNA. Bands representing free
DNA were from reaction 1, the CLOCK:BMAL1:E-box com-
plex from reaction 2, and the CRY:CLOCK:BMAL1:E-box
complex from reaction 3 were excised from the gel, and DNA
was eluted from the gel slices and run on a 10% denaturing
polyacrylamide gel that was visualized by autoradiography.
Pulldown Assay for Protein-Protein Interactions—Purified
recombinant proteins at 0.1 nMweremixed in 200l of binding
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 100 g/ml of
BSA, 0.05% Nonidet P-40) and incubated at 22 °C for 15 min.
Then 20 l of either FLAG- or V5-agarose (Sigma) beads
were added and themixture was incubated at 4 °C for 90min.
Then, the beads were washed with 1 ml of ice-cold binding
buffer 4 times and after the final wash resuspended in 25 l
of SDS loading buffer and heated at 95 °C for 5 min. The
proteins were then separated on SDS-PAGE and visualized
by immunoblotting.
Chromatin Immunoprecipitation—We used a previously
described dual cross-link ChIP procedure (26) with somemod-
ifications.Detailed procedures are described under supplemen-
tal “Methods”.
siRNA Treatment, RNA Extraction, and Reverse Tran-
scription—siRNAs specific for mCry1, mCry2 (SMARTpool
siRNA, L-040485-01-0005, and L-014151-01-0005) and
CYCP-B control siRNA (D-001820-02) were purchased from
Dharmacon. Transfections were performed with 50 pmol of
siRNAs using the transfection reagent RNAi Max (Invitrogen).
Following a 48-h transfection the cells were collected and total
RNA was extracted using the RNeasy Mini Kit (Qiagen). Total
RNA (500 ng) was reverse transcribed with oligo(dT)20 using
SuperScript III (Invitrogen) according to the manufacturer’s
instructions.
Quantitative Real-time RT-PCR—Real-time PCR assays
were performed by using an ABI 7300 system (Applied Biosys-
tems) and MaximaTM SYBR Green/ROX qPCR Master Mix
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(Fermentas). Quantitation of ChIP was performed with the
primer sets in supplemental Table S1. Each sample was ana-
lyzed in triplicate. To compare ChIP data from different chro-
matin samples, signals obtained from each chromatin sample
were divided by signals obtained from the corresponding input
sample and are presented as “% input.”
Quantitation of Dbp mRNA level was performed with the
primer sets (mDbpF andmDbpR). Each sample was analyzed in
triplicate, and cycle thresholds of individual genes were nor-
malized to the corresponding GapdhmRNA expression values
obtained with the primer set (mGapdhF and mGapdhR). Rela-
tive mRNA levels were assessed by defining the value of
CYCP-B control RNA treatment as one in each experiment.
Sequences of the primers sets used in this study are listed under
supplemental Table S1.
RESULTS
Purification of Mouse Clock Proteins—To test the conven-
tional TTFL model that posits that the CLOCK:BMAL1 het-
erodimer drives the transcription of target genes and that the
PER:CRY heterodimer binds to and interferes with the transac-
tivator function of CLOCK:BMAL1, we purified these proteins
using baculovirus or mammalian expression systems. Fig. 1A
shows the purified full-length proteins analyzed by SDS-PAGE
and Coomassie Blue staining. We found that BMAL1, CRY1/2,
and PER1/2 could be expressed individually and purified in rea-
sonable quantities using immunoaffinity chromatography.
However, when CLOCK was expressed alone, it was somewhat
unstable and insoluble as reported previously (27).When coex-
pressedwith BMAL1, CLOCK could be purified in a reasonable
yield and with one-to-one stoichiometry, as shown in lane 1.
We used both mouse CRY1 and CRY2 and mouse PER1 and
PER2 in our experiments as dictated by availability and practi-
cal considerations. In addition, we used human CRY1 for the
CRY1:PER2 heterodimer and humanCRY1 alone as a reference
cryptochrome in experiments with this heterodimer. Because
most of the experimentswere performedwithmouse clock pro-
teins we will omit the “m” designation for the sake of simplicity.
Formation of CLOCK:BMAL1:CRY1 Ternary Complex on
E-boxDNA—BothCRYs and PERs bind to theCLOCK:BMAL1
heterodimer as evidenced by yeast two-hybrid assays, protein-
protein pulldown, and co-immunoprecipitation assays (5–7, 9).
These findings led to the original TTFL model that proposed
that the PER:CRY heterodimer (or a higher order oligomer)
binds to the CLOCK:BMAL1 complex on E-boxes of the cog-
nate promoters and suppresses the transactivation function of
the complex. In addition, reporter gene assays have led to the
conclusion that CRY is the major repressor of CLOCK:BMAL1
by direct interaction with either CLOCK alone or with both
CLOCK and BMAL1 in amultiprotein complex (5, 7, 28). How-
ever, a recent study that, in addition to reporter gene assays,
employed co-immunoprecipitation assay and behavioral anal-
ysis of transgenic mice overexpressing PER2 or CRY1 con-
cluded that PER2 directly binds to CLOCK:BMAL1 and brings
CRY1 to the complex (17). We wished to test these and similar
models by conducting experiments with purified proteins.
First, we tested the binding of CLOCK:BMAL1 to a 14-bp
duplex containing an E-box by gel mobility shift assay (25). As
seen in Fig. 1B, CLOCK:BMAL1 binds to the E-box specifically
and this binding is competed out with 100-fold excess oligomer
of the same sequence but not with an oligomer having a
mutated sequence (lanes 3 and 4), as reported previously (25).
Importantly, the retarded band is supershifted both with anti-
CLOCK and anti-BMAL1 antibodies (anti-Myc as negative
control), indicating that the protein-DNA complex contains
both the CLOCK and BMAL1 proteins (lanes 6 and 8).
Next, we investigated the effect of CRY1 on the CLOCK:
BMAL1:E-box ternary complex. In Fig. 1C the complex was
incubated with increasing concentrations of CRY1 and then
analyzed by gel electrophoresis. Two conclusions emerge from
this figure. First, CRY1 does not disrupt the ternary complex
under our experimental conditions as evidenced by the inten-
sity of the CLOCK:BMAL1:DNA band in the absence and pres-
ence of CRY. Second, in the presence of CRY, in particular at
the highest CRY concentration used in this experiment, there is
a slight supershift of the protein-DNAcomplex, suggesting that
CRY associates with CLOCK:BMAL1 on DNA. To further
examine this association, we attempted to supershift the pre-
sumed CRY:CLOCK:BMAL1:DNA complex with antibodies
against each of the 3 proteins. As seen in Fig. 1D the complex is
nearly completely supershifted by anti-CLOCK and anti-
BMAL1 antibodies and a significant fraction of it was super-
shifted with anti-CRY antibodies as well. In Fig. 1E we show
that with high concentrations of CRY protein, most of the pro-
tein-DNA complex is supershifted, indicating that under
appropriate assay conditions nearly all of the CLOCK:BMAL1:
E-box complex is bound to CRY1. In addition, CRY2 protein,
but not Drosophila CRY binds to the CLOCK:BMAL1:E-box
complex in our assay (supplemental Fig. S1A). The CLOCK:
BMAL1:CRY1 complex co-purified frommammalian cells also
showed clear binding activity to the E-box as a ternary complex
(supplemental Fig. S1, B and C). To ascertain the specificity of
CRY1 binding to CLOCK:BMAL1 on an E-box we performed
additional experiments to test effects of CRY on other E-box-
binding proteins including the BMAL1 homodimer and the
MAX homodimer (29, 30). Fig. 1F shows that the association of
CRY1 with the CLOCK:BMAL1:E-box complex is specific,
because the mobility of the BMAL1:E-box or the MAX:E-box
complexes are not affected by CRY1 or CRY1 plus anti-CRY1
antibody under conditions where the entire CRY1:CLOCK:
BMAL1:E-box is supershifted by the anti-CRY1 antibody.
These data unambiguously show that the CRY protein does not
dissociate CLOCK:BMAL1 from the E-box by physical interac-
tion; in contrast, it binds to the CLOCK:BMAL1:E-box com-
plex with high specificity and without the intermediacy of
another protein.
Footprint of CLOCK:BMAL1—The data in Fig. 1 show that
under appropriate reaction conditions nearly all of the BMAL1:
CLOCK:E-box complexes are associated with CRY1. Yet, even
under conditions of saturating concentration of CRY1 only a
minor CRY1-induced supershift is detected in the DNA-pro-
tein complex. This could be due either to the relatively small
molecular mass of CRY1 (65 kDa) compared with that of the
CLOCK:BMAL1 heterodimer (180 kDa) or to the shape and
electrostatic charge of the proteins involved. It is well known
that the degree of mobility shift of DNA-protein complexes is
Biochemical Analysis of the Clock
JULY 22, 2011 • VOLUME 286 • NUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 25893
not linear with the size of the binding protein. Indeed, as seen in
Fig. 1F the BMAL1 homodimer:DNA complex migrates slower
than the CLOCK:BMAL1-DNA complex even though the lat-
ter complex possesses amolecularmass25 kDamore than the
former. Hence, we considered the possibility that the CRY1:
CLOCK:BMAL1 complex on an E-box, which is clearly detect-
able only by anti-CRY1 antibody induced supershift in gel retar-
dation experiments, may bemore readily detectable by DNase I
footprinting, which has higher resolution than the gel retarda-
tion assay. For DNase I footprinting, we used a 60-bp fragment
P2GS encompassing an E-box in the mouse Per1 promoter,
which was shown to be functional in a reporter gene assay (9)
(Fig. 2A). In the gel mobility shift assay using this fragment we
obtained results similar to those obtained with the 14-bp E-box
fragment used in Fig. 1 (Fig. 2B and supplemental Fig. S1D).
Importantly, in the presence of anti-CRY1 antibodies, most of
theDNA-protein complexwas supershifted in the reaction that
included CRY1 in the reaction mixture. Interestingly, when
these complexes were probed by DNase I footprinting the
CLOCK:BMAL1 heterodimer produced a rather small foot-
FIGURE 1. Ternary complex of CRY:CLOCK:BMAL1 on an E-box. A, Coomassie Blue staining of SDS-polyacrylamide gels of mouse core clock proteins. The
locations of the clock proteins are marked by asterisks to differentiate from nonspecific contaminants present in some of the preparations. When co-expressed,
CLOCK and BMAL1 both become partially phosphorylated, and the phosphorylated and non-phosphorylated forms of each protein were run in the gel as
doublets. The phosphorylated form of each can be converted to the non-phosphorylated form by incubation with -phosphatase (data not shown). B, elec-
trophoretic mobility shift assay with the CLOCK:BMAL1 heterodimer (0.2 nM). The target was a 32P-labeled 14-bp duplex M34 with the E-box sequence (1 nM).
The specificity of the complexes was confirmed by competition with a 100-fold excess of non-radioactive wild-type (M34) or mutant duplexes (GCM34) and by
supershifting the DNA-protein complexes with the appropriate antibodies. Substrate sequences (one strand of each duplex) are listed under the gel. C, effect
of CRY on the mobility of the CLOCK:BMAL1:E-box complex. The E-box duplex (1 nM) was incubated with fixed amounts of CLOCK:BMAL1 dimer (0.2 nM) and
increasing amounts of CRY1 (0.1, 0.3, and 1 nM) as indicated. A line parallel to the leading edge of the CLOCK:BMAL1:E-box complex is drawn to indicate the
subtle change in mobility of the protein-DNA band upon addition of CRY1. D, antibody supershift in the presence of various combinations of CRY1 (0.2 nM) and
CLOCK:BMAL1 dimer (0.2 nM). The mobility of the supershifted CRY:CLOCK:BMAL1:E-box complex is indicated with an asterisk. E, effect of CRY1 concentration
on the extent of the CRY1:CLOCK:BMAL1:E-box complex formation. CLOCK and BMAL1 (0.2 nM) were first incubated with the E-box duplex (1 nM). Then
increasing amounts of CRY1 (0.1, 0.3, and 1 nM) were added, followed by addition of a constant amount of anti-CRY1 antibody (1 g) to supershift protein-DNA
complexes containing CRY1. F, binding of CRY1 to the CLOCK:BMAL1:E-box is dependent on the presence of CLOCK in the complex. CLOCK:BMAL1 (0.2 nM),
BMAL1(2 nM), or MAX (0.5 nM) E-box-binding proteins were incubated with the E-box oligomer followed by CRY1 (1 nM) or CRY1 plus anti-CRY1 antibody. Note
that only the CLOCK:BMAL1:E-box complex is supershifted upon addition of CRY1 plus anti-CRY1 (indicated by an asterisk) CK-BM (CLOCK:BMAL1), BM (BMAL1),
and MAX.
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print of 8-bp centered around the E-box (Fig. 2C), and this
footprint was not affected by CRY1 under conditions known to
produce the CRY1:CLOCK:BMAL1 complex on the E-box.
Even though this result did not provide further insight on the
anatomy of the CLOCK:BMAL1:CRY complex, the footprint is
consistent with the known properties of interactions of bHLH
family protein with DNA (30). In the complex of BMAL1 and
CLOCK, both of which are bHLH-PAS domain proteins, con-
tact with DNA is made with the bHLH domains, which are
located at the extreme N terminus of each member of the het-
erodimer. The extended structure of this family of proteins
explains the small footprint and also explains the lack of effect
of CRY1 on the footprint because CRYs bind to the PAS
domains and the C-terminal domains distant from the DNA
contact region (31, 32).
Effect of PER on CLOCK:BMAL1:E-box and CRY:CLOCK:
BMAL1:E-box Complexes—Although CRY is the dominant
repressor of the CLOCK:BMAL1 transactivation function as
shown by reporter gene assays (7) and transcription assays with
Cry1/ Cry2/ knock-out mice (33), numerous studies sug-
gest that CRYworks as a heterodimer with PER in the TTFL (3,
22). The coordinated inhibitor function of PER and CRY can be
classified by the following different steric models: (a) PER:CRY
complex binds to CLOCK:BMAL1 off DNA and disrupts the
heterodimer or interferes with its binding to E-boxes in the
cognate promoters. (b) PER:CRY binds to CLOCK:BMAL1
through CRY and blocks the transactivation function of the
transcription factor (22). (c) The PER:CRY complex binds to
CLOCK:BMAL1 by direct binding of PER to the complex, and
not the other way around, even though CRY is considered the
nominal repressor (17). To differentiate among these models,
we investigated the combined effects of PER and CRY on the
CLOCK:BMAL1:E-box complex. Because PER2 appears to be
more important than PER1 for normal clock function in mice
(17, 34), we used PER2 in most of our experiments.
The various models were tested by gel mobility shift assays.
Fig. 3A and supplemental Fig. S1E show that, in contrast to
CRY1 and CRY2, PER1 and PER2 do not affect the mobility of
the CLOCK:BMAL1: E-box complex. However, because even
with CRYs the mobility shift is subtle, this finding alone does
not prove that PER2does not associatewith the complex. In Fig.
3B we employed the more stringent test of antibody-mediated
band supershifting. When Myc-tagged CRY1 and PER2 were
added to the CLOCK:BMAL1:E-box reaction mixture, Myc-
CRY1 slightly retarded the DNA-protein band, which, impor-
tantly, upon the addition of Myc antibodies was nearly com-
pletely supershifted. In contrast, Myc-PER2 at the same
concentration as Myc-CRY1 had no effect on the mobility of
theCLOCK:BMAL1:E-box complex, andmost importantly, the
addition of anti-Myc antibodies to theMyc-PER2 plus CLOCK:
BMAL1:E-box reaction mixture did not affect the mobility of
the protein-DNA band. We conclude that under our reaction
conditions PER2 does not directly bind to the CLOCK:BMAL1:
E-box complex.
Failure of PER2 to bind to the CLOCK:BMAL1:E-box was
unexpected. We considered the possibility that solitary PER2
may not be properly folded, and that in vivo PER2 might be
mostly associated with CRY and hence the PER:CRY complex
may represent the functionally relevant form of the protein.
With these considerations, we purified the PER2:hCRY1 com-
plex and the hCRY1 as a control (Fig. 3C) and tested them in gel
mobility shift assays. The results are shown in Fig. 3D. As
expected, CRY1 alone supershifts the CLOCK:BMAL1:E-box
complex. Surprisingly, however, the PER2:CRY1 heterodimer
does not affect migration of the CLOCK:BMAL1:E-box even
thoughCRY1 alone at a concentration equivalent to its concen-
tration in the PER2:CRY1 heterodimer clearly retards the pro-
tein-DNA band. The most parsimonious explanation of these
data is that PER2 interferes with binding of CRY1 to the
CLOCK:BMAL1:E-box complex. However, because such a
FIGURE 2. DNase I footprint of clock proteins on an E-box. A, schematic representation of the mPer1 promoter illustrating the relative position and the
sequence of one strand of the 60-bp duplex encompassing the mPer1 E-box2. CDS indicates coding DNA sequence. B, EMSA with the 60-bp duplex and
supershift of the protein-DNA (0.4 nM CRY and 0.2 nM CLOCK:BMAL1 dimer) complexes with the indicated antibodies. The asterisk identifies the supershifted
CRY:CLOCK:BMAL1:E-box complex. C, DNase I footprint of the clock protein-DNA complexes. The position of the E-box is indicated.
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conclusion is contrary to the generally held view that PER either
mediates the binding of CRY to CLOCK:BMAL1, or is in a
complex with CRY that binds to the CLOCK:BMAL1:DNA
complex, we were concerned that the lack of binding by PER2:
CRY1 might have been caused by an inactive protein prepara-
tion. Therefore, to test if indeed PER2 interfered with binding
of CRY to the CLOCK:BMAL1:E-box complex we performed
gel mobility shift assays to test the effects of PER on a pre-
assembled CRY:CLOCK:BMAL1:E-box complex. The results
in Fig. 3, E and F, show that supershifting of the CLOCK:
BMAL1:E-box complex by CRY is abolished when PER2 is
added to the complex as evidenced by the migration of the
protein-DNAbandwithout (Fig. 3E) andwith (Fig. 3F) antibod-
ies against the affinity tag on CRY1. Based on these findings, we
conclude that PER2 does not recruit CRY to CLOCK:BMAL1
bound to the promoter of the cognate genes, but it actually
impairs its binding.
In Vitro Interactions Among Purified CLOCK Proteins—Fail-
ure to detect an interaction of PER2 with CLOCK:BMAL1 on
DNA was surprising because the interactions of PER2 with all
clock proteins has been demonstrated by numerous studies
(17). Hence, to ascertain whether the PER2 that was used in
mobility shift experiments was active, we tested it for protein-
protein interactions with the other clock proteins by co-immu-
noprecipitation of purified proteins. In Fig. 4 we compare the
binding of PER2 and CRY1 to each other, and to BMAL1 and
CLOCK. As expected, individually purified PER2 and CRY1
interact with one another (Fig. 4A). Significantly, PER2 binds to
FIGURE 3. Effect of PER on clock protein-DNA complexes. A, effect of PER2 on the CLOCK:BMAL1:E-box complex. The 14-bp E-box duplex (1 nM) was
incubated with CLOCK:BMAL1 (0.2 nM) and then increasing concentrations (0.2, 0.6, and 1.5 nM) of PER2, CRY1, or CRY2 were added, and the protein-DNA
complexes were analyzed by EMSA. The dashed line indicates the leading edge of migration of the CLOCK:BMAL1:E-box complex. Note the lack of effect of PER2
on the mobility of this complex (lanes 1–3). In contrast both CRY1 (lanes 6–8) and CRY2 (lanes 9–11) retard the DNA-protein complex. B, analysis of the
composition of the protein-DNA bands by antibody supershift. In addition to CLOCK:BMAL1 (0.2 nM) equal concentrations of either Myc-PER2 (1 nM) or
Myc-CRY1 (1 nM) were included in the reactions followed by anti-Myc antibodies in the last two lanes. Note the supershift of the protein-DNA band formed in
the presence of Myc-CRY1 (lane 5) but not Myc-PER2 (lane 6). C, Coomassie Blue staining of SDS-PAGE showing the hCRY1 and PER2:hCRY1 used in the
electrophoretic mobility shift assay. D, effects of hCRY1 and PER2:hCRY1 on CLOCK:BMAL1:E-box complexes. Increasing concentrations (0.1, 0.3, and 1 nM) of
hCRY1 or the PER2:hCRY1 complex were added to the reactions as indicated before electrophoresis. Note the supershift caused by hCRY1 (lanes 4 and 5) but
not by the PER2:hCRY1 complex (lanes 6 – 8) containing the same concentrations of hCRY1 as in lanes with hCRY1 alone. E and F, PER2 removes CRY1 from the
CRY1:CLOCK:BMAL1:E-box complex. The E-box duplex was incubated with the indicated proteins: 0.2 nM CLOCK:BMAL1 dimer and 0.3 nM hCRY1 (in panel E) or
0.3 nM Myc-CRY1 (in panel F) before separating on a native gel. Note that the presence of hCRY1 causes a slight retardation of the CLOCK:BMAL1:E-box complex
(panel E, lane 3), which is reversed by inclusion of increasing concentrations (0.2, 0.6, and 1.2 nM) of PER2 (panel E, lanes 4 – 6). The effect of PER2 on removing
CRY1 from the protein-DNA complex is more clearly shown when the anti-Myc antibody supershifted Myc-CRY1:CLOCK:BMAL1:E-box complex is incubated
with increasing concentrations of PER2 (panel F, lanes 3–5).
FIGURE 4. Protein-protein interactions among purified clock proteins in vitro. CLOCK, BMAL1, CRY, and PER protein were individually purified from insect
cells. Proteins (0.1 nM) were mixed as indicated, one of the clock proteins was immunoprecipitated and immunoprecipitates were tested for the other
interacting proteins by immunoblotting (IB). A, PER2 and CRY1 interaction. B, interaction of BMAL1 with CRY1 and PER2. C, interaction of CLOCK with CRY1 and
PER2. The input lanes contain 20% of the proteins used in the immunoprecipitation (IP) reactions.
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both BMAL1 and CLOCK with higher affinity than CRY1 (Fig.
4, B and C). Although quantitative binding experiments with
recombinant proteins must be considered with some caution,
these data nevertheless do show that PER2 used in ourmobility
shift assays is at least as active as CRY1 in protein-protein inter-
actions with CLOCK and BMAL1. Hence, we conclude that the
failure to detect binding of either PER2 or the PER2:CRY1 com-
plex to the CLOCK:BMAL1:E-box ternary complex is not due
to themisfolding or an otherwise inactive form of PER2; rather,
it is a manifestation of an intrinsic property of the core clock
system.
Effect of Mutations in Core Clock Genes on Binding of Cryp-
tochrome to Target Promoters in Vivo—The in vitro data we
have presented indicate that CRY may be recruited to target
promoters by direct protein-protein interactions with CLOCK:
BMAL1 bound to E-boxes in cognate promoters. To test this
prediction in vivo we carried out ChIP assays with CRY and
CLOCK antibodies in cell lines frommice in which clock genes
have been knocked out (supplemental Fig. S2, B and C). ChIP
results are shown in Fig. 5 and supplemental Figs. S3 and S4.
Several noteworthy conclusions emerge from ChIP assays with
anti-CRY1 antibodies, shown in orange in Fig. 5A. First, in
agreement with the in vitro data, CRY1 binds independently of
PER1 and PER2 proteins to E-box elements in the promoter
regions of both Per1 and Per2 genes. Second, in contrast to the
in vitro data, which show that CRY1 binds to the CLOCK:
BMAL1:E-box complex but not to the BMAL1:E-box complex
(Fig. 1F), the binding of CRY1 to E-box in vivo is independent of
CLOCK. However, considering that BMAL1 is capable of mak-
ing heterodimers with other PAS domain proteins such as
FIGURE 5. CRY1 binds E-boxes in Per1 and Per2 promoters in the absence of PER protein and affects CLOCK-BMAL1 dynamics at cognate promoters in
mouse fibroblasts. Wild-type or clock mutant mouse fibroblasts were used in ChIP experiments to determine the effects of null mutations of various clock
genes on binding of CRY1 and CLOCK to target promoters. ChIP was analyzed by quantitative PCR and the values represent the average of three experiments 
S.E. From left to right, 4 columns of bar graphs show the ChIP data from different knock-out cell lines. From top to bottom, the four rows of graphs show binding
to the Per1 Ebox2 or the Per2 Ebox2 (22, 49), as indicated on the left. A, CRY1 ChIP (represented by orange color). Dual cross-linked nuclear extracts were isolated
from fibroblasts of the indicated genotypes and subjected to ChIP. The immunoprecipitation was performed with anti-CRY1 or no antibody control. B, CLOCK
ChIP (represented by blue color). The immunoprecipitation was performed with anti-CLOCK polyclonal antibodies or IgG control. C, schematic diagram
summarizing how CLOCK, BMAL1, and CRY1 occupy E-boxes in Per1 and Per2 promoters in fibroblasts with various genetic backgrounds.
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NPAS2, this was to be expected (35–37). Indeed, ChIP reveals
that binding of CRY1 to both Per1 and Per2 E-boxes is abso-
lutely dependent on BMAL1 (Fig. 5A, right column). These data
confirm the conclusion from the in vitro experimentswith puri-
fied proteins that CRY binds directly to CLOCK:BMAL1 situ-
ated on an E-box.
Next, we investigated the binding of CLOCK to the same
E-boxes (Fig. 5B, blue). The results reveal several interesting
patterns regarding the interactions of the core clock proteins
with clock gene promoters and with one another. First, the
absence of CRY enhances the occupancy by CLOCK of E-boxes
in both Per1 and Per2 promoters even though it has been
reported that in mouse liver, in the absence of CRY, the level of
CLOCK is reduced (22). It is conceivable that CRY promotes
post-translational modifications of CLOCK that facilitates its
removal from the cognate promoters (11). Second, in contrast
to the absence of Cry genes, the absence of Per genes has only a
modest stimulatory effect on CLOCK occupancy of Per1 and
Per2 E-boxes. This is possibly because in Per1/ Per2/ cells,
both CRY1 and CRY2 levels are lower in the nucleus (22),
resulting in only a modest effect on the CLOCK protein level
and its occupancy of E-boxes. Finally, in the Bmal1/ back-
ground, there is no significant binding of CLOCK to the Per1
and Per2 promoters, consistent with the canonical clock model
that BMAL1 is an irreplaceable component of the positive arm
of the TTFL.
Overall, the ChIP experiments support the conclusions from
the gelmobility shift assays with purified proteins that CLOCK:
BMAL1 binds to E-boxes in cognate promoters, that recruit-
ment of CRY to the CLOCK:BMAL1:E-box ternary complex is
independent of PER and support previous reports that BMAL1,
in the absence of CLOCK, can make heterodimers with other
PAS domain proteins such as NPAS2 to regulate transcription
(38) (Fig. 5C). Hence, in vitro experiments should be considered
as essential tools for testing any molecular model for the mam-
malian circadian clock.
Probing for PER2 Protein Binding in Vivo to E-boxes in Pro-
moters of CLOCK:BMAL1 Controlled Genes—The in vitro
experiments showed that PER protein does not bind to the
CLOCK:BMAL1:E-box complex. To examine this issue in vivo,
we conducted ChIP assays with polyclonal anti-PER2 antibod-
ies and wild-type mouse skin fibroblast cells. However, our
experiments failed to reveal any measurable binding of PER2
protein to either Per1 or Per2 promoters (data not shown).
Because ChIP assay results may be dramatically affected by the
quality of the antibodies, we carried out ChIP assays using anti-
FLAG antibodies in fibroblast cell lines that stably express
CRY1-FLAG (control) or PER2-FLAG proteins. The immuno-
precipitation assay results in Fig. 6A show that PER2-FLAGand
CRY1-FLAG were precipitated at comparable levels from the
two stable lines. CLOCK and BMAL1 bound to both FLAG-
tagged proteins, more strongly to PER2-FLAG. Therefore, both
FLAG-tagged proteins are active. However, the ChIP assay
results with anti-FLAG antibodies in Fig. 6B show that CRY1-
FLAG, but not PER2-FLAG, can bind to Per1 and Per2 promot-
ers. FLAG-tagged PER2 failed to bind these regions when the
FLAG tag was at either the C terminus (Fig. 6B) or N terminus
(data not shown). These results indicate that at least in skin
fibroblast, PER2 does not bind to these E-boxes. The strong
interaction of PER2 with CLOCK and BMAL1 probably occurs
only when these proteins are off DNA.
Effect of Cryptochrome on Transcription of a Clock-controlled
Gene in the Presence and Absence of PER—The data presented
so far show that CRY can bind to CLOCK:BMAL1 situated at
E-boxes of target promoters without the help of PER. To deter-
mine whether this binding affects transcription we used a
CLOCK:BMAL1-controlled gene with high amplitude circa-
dian oscillation, Dbp, as a readout (8). First, we confirmed that
as in the case of thePer1 andPer2 promoters, CRY1 binds to the
E-box in theDbp gene independently of PER (Fig. 6C). Then to
determine the effects of CRY binding on Dbp transcription in
the absence and presence of PER,we down-regulatedCRY1 and
CRY2 in the wild-type and Per mutant background and ana-
lyzed the cells for Dbp transcription as measured by quantita-
tive RT-PCR. Clearly, the reduction in CRY level (Fig. 6D) is
accompanied by a proportional increase in the level of Dbp
mRNA (Fig. 6E), consistent with the consensus clock model
whereby the binding of CRY to CLOCK:BMAL1 at the E-boxes
of the target genes represses the transcription of these genes.
Importantly, both in wild-type and Per1/ Per2/ cell lines,
theDbpmRNA level goes up similarly upon down-regulation of
CRY. These findings suggest that CRY is the predominant
repressor of Dbp, which is regulated with a robust rhythmicity
by the CLOCK:BMAL1 transcriptional activator.
DISCUSSION
The TTFL, which was proposed over a decade ago as the
mechanisticmodel for themammalian circadian clock, remains
as the starting point for the more detailed models that have
been elaborated subsequently as new levels of regulation were
discovered.However, despite the extensive genetic and cell bio-
logical data that exist in support of the canonical model, a rig-
orous biochemical test of the model has been lacking. Clearly,
biochemical experiments with purified proteins are necessary
to test some key points of the canonical model. Here, we
attempted to address some key features of the model by con-
ducting experiments with purified proteins in vitro and ChIP
assays with cell lines mutated in various clock genes. Our find-
ings support some aspects of the conventional model, but also
suggest that some features of the canonical model need to be
revised. A revised model consistent with our data is shown in
Fig. 7 and is elaborated below.
Mechanism of CRY Repression of CLOCK:BMAL1 Transcrip-
tionalActivation—Our in vitro and in vivo findings are in agree-
mentwith previous reports in showing that bHLH-PASdomain
proteins CLOCK and BMAL1 make a heterodimer, which
binds to E-boxes in the promoters of cognate genes and func-
tions as a transcriptional activator. Furthermore, our reconsiti-
tuted system and ChIP assays clearly demonstrate that CRY
interacts strongly with CLOCK:BMAL1:E-box complexes.
Binding was BMAL1 dependent both in vitro and in vivo, indi-
cating that CRY is directly recruited to the E-box by a (CLOCK/
NPAS2):BMAL1 heterodimer. Also of considerable impor-
tance is our finding that this binding of CRY is independent of
PER: ChIP assays clearly demonstrated that CRY binds to reg-
ulatory E-boxes even in Per knock-out cells, and in vitro, PER
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was not only unnecessary for, but actually impaired CRY bind-
ing to the BMAL1:CLOCK:E-box DNA complex. Binding of
CRY to the transactivator complex in the absence of PER is
biologically meaningful, because we found that in Per1/
Per2/ knock-out cells, CRY down-regulated BMAL1:
CLOCK-activated transcription of the Dbp gene. All of these
results are in agreement with a reporter gene assay that found
the inhibition of transactivation by CRY depends on the inter-
action of CRYwith either CLOCKor bothCLOCKandBMAL1
bound to DNA in S2 cells, which express no other mammalian
clock proteins (5). Thus, independently of PER, CRY directly
interacts with the BMAL1:CLOCK:E-box complex in a
BMAL1-dependent manner to form a stable complex on DNA
in which the transactivator function of CLOCK:BMAL1 is
inhibited by CRY.
In addition to blocking transactivation, CRYmaymediate an
enzymatic function. We found that CLOCK occupied the Per1
E-box2, and to a lesser extent Per2 E-box2, at higher frequency
in Cry null cells than wild-type cells, suggesting that CRY may
destabilize the CLOCK:BMAL1:E-box complex in vivo (Fig.
7D). Relevant to this is a report showing that CLOCK:BMAL1
binds rhythmically to the Dbp promoter (8). Because under all
experimental conditions tested, CRYdid not destabilize the ter-
nary complex in vitro, we ascribe the discrepancy between the
in vivo and in vitro data to the effect of CRY on the phosphor-
ylation status of other clock proteins including PER, CLOCK,
and BMAL1 in vivo as it is known that the phosphorylation
status of CLOCK affects its protein stability and DNA binding
activity (12, 19, 39).
Regulation of the CRY:CLOCK:BMAL1:E-box Complex by
PER—Although it is clear that PER and CRY bind to one
another with high affinity, the significance of this interaction
for their respective functions has been a matter of considerable
debate. Some reports suggest that CRY is required for
nuclear transport of PER, and others indicate that, in fact,
CRY depends on PER for nuclear entry (40, 41). In addition,
FIGURE 6. CRY1 represses Dbp transcription independently of PER1 and PER2 in mouse fibroblasts. A, expression of clock proteins in mouse fibroblasts
stably expressing CRY1-FLAG or PER2-FLAG. The cell lines stably expressing the tagged proteins are identified above each lane. Nuclear extracts prepared
from a control cell line, Mock, and the two cell lines expressing PER2-FLAG or CRY1-FLAG, were subjected to immunoprecipitation (IP), and the
immunoprecipitates were probed by immunoblotting (IB) for the clock proteins using antibodies listed on the left side. Blots were cut to envision the
proteins listed on the right. Note the PER and CRY proteins were double immunoblotted with anti-FLAG antibodies, and with anti-CRY or anti-PER
antibodies. The input lanes contain 10% of the material used in the IP. Note that the PER2-FLAG protein pulls down CLOCK, BMAL1, and CRY1 proteins,
and the CRY1-FLAG protein pulls down CLOCK and BMAL1 but not PER2 presumably because the poor sensitivity of the anti-PER2 antibody (first row)
does not permit detection of the endogenous PER2 signal. B, ectopic CRY1 binds to the E-boxes of Per1 and Per2, but ectopically expressed PER2 does
not. ChIP assays were performed using anti-FLAG antibodies with the cell lines indicated on the x-axis, which express comparable levels of PER2-FLAG
or CRY1-FLAG. Mock is a normal mouse fibroblast line as in A. C, binding of CRY1, independently of PER, to the E-box in the Dbp promoter. Wild-type or
Per1/ Per2/ mouse skin fibroblasts were subjected to ChIP after dual cross-linking with either CRY1 antibodies or no antibody control. Top panel,
semi-quantitative analysis of the ChIP data. Bottom panel, ChIP results of the Dbp E-box and a control non-regulatory sequence (Dbp 3) were analyzed
by quantitative PCR. D, down-regulation of CRY1 and CRY2 by siRNA in wild-type (Per/) and Per1/Per2/ mouse skin fibroblasts (Per/) using
antibodies against the proteins listed on the right. Whole cell extracts from cells treated with the indicated siRNAs were analyzed by immunoblotting;
Cyclophilin-B (CycP-B) was used as a control for siRNA specificity and Actin was used as a loading control. E, down-regulation of CRY both in wild-type and
Per null cells leads to up-regulation of Dbp transcription. The relative abundance of Dbp mRNA was determined by quantitative RT-PCR. Results obtained
with Cry1/2 siRNA were normalized to results obtained with CycP-B siRNA, which were given a value of 1.
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it has been reported that PER and CRY are required for the
stability of one another, which somewhat complicates the
interpretation of the results obtained with CRY or PER
mutant mice and cell lines.
Similarly, even though yeast two-hybrid assays and co-im-
munoprecipitation experiments have revealed that in pairwise
tests bothCRY andPERdirectly interact with bothCLOCKand
BMAL1, these tests do not address the question of whether
these interactions occur both off and on DNA. Some studies
have concluded thatCRY is the bona fide repressor that binds to
CLOCK:BMAL1 and brings along PER to E-boxes in target pro-
moters (22). However, a recent study that employed co-immu-
noprecipition and behavioral analysis of CRY1- or PER2- over-
producingmice suggested that PER2 bridges CRY andCLOCK:
BMAL1 bound toDNA to drive the circadian negative feedback
loop (17).
In our study, we focused on the question of CRY/PER inter-
actions with CLOCK and BMAL1 both on and off DNA in a
defined system. These in vitro data were further verified by
ChIP experiments in mouse fibroblasts to ascertain that the
results we observed with the in vitro systemwere not an artifact
of the reaction conditions. Contrary to our expectations, based
on numerous reports indicating an essential role for PER in
repressing CLOCK:BMAL1 in vivo, and based on in vitro data,
including our own, which show strong PER/CLOCK/BMAL1
interaction off DNA, we were unable to detect the formation of
a PER:CLOCK:BMAL1:E-box complex under a variety of
experimental conditions. Furthermore, the presence of CRY in
the reaction mixture does not promote the recruitment of PER
to the CLOCK:BMAL1:DNA complex. In contrast, ChIP assays
failed to reveal measurable binding of PER2 protein to either
Per1 or Per2 promoters in wild-type fibroblasts. This is consis-
tent with our model that CRY binds directly to the BMAL1:
CLOCK:E-box complex (Fig. 7C). However, the lack of PER2
binding to cognate promoters in fibroblasts differs from the
findings with ChIP using liver nuclei (42).Most likely, liver cells
FIGURE 7. Model for the roles of CRY and PER in the TTFL of the mammalian circadian clock. A and B, during the day (or subjective day) CLOCK:BMAL1 bind
to the Per and Cry promoters and activate their transcription. In addition, REV-ERB/ROR regulates Bmal1 transcription. The PER and CRY proteins make
heterodimers and enter the nucleus. Within the nucleus there is a dynamic equilibrium of the PER:CRY complex and solitary PER and CRY (most likely in
complexes with other proteins); C and D, during the night (or subjective night), solitary CRY binds to the CLOCK:BMAL1:E-box ternary complex and inhibits the
transcription of Per and Cry (as well as other CLOCK:BMAL1 controlled genes) both by physically interfering with the transactivation function of CLOCK:BMAL1,
as well as by interfering with the post-translational modification of these proteins, which seems to be important for their transactivation functions. Data from
mouse liver ChIP shows that PER2 can bind to the promoter of Bmal1 and control its transcription independently of CRY (42). This is a highly simplified model
to emphasize that CRY can directly interact with CLOCK:BMAL1 on DNA to repress its transactivator function and that similarly, based on data from other
studies (5, 42), PER2 can regulate the transcription of genes in the “stabilizing loop” of the clock independently of CRY to affect their transcription. NRE, nuclear
responsive element.
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express proteins, which are not expressed in fibroblasts and
interact with PER2 and recruit it to the target promoters in a
tissue-specific manner.
Most surprisingly, perhaps, was our finding that even though
solitary CRY binds to a CLOCK:BMAL1:E-box in vitro, the
CRY:PER heterodimer does not, suggesting that PER interferes
with binding of CRY to the transactivator on DNA. In support
of this conclusion, we found that when PER was added to the
CRY:CLOCK:BMAL1:E-box complex, CRY was removed from
the complex. This is consistent with amodel whereby CRY is in
a dynamic equilibrium with CLOCK:BMAL1:E-box, and in the
presence of PER at a sufficiently high concentration in the
nucleus, all CRY becomes trapped in the form of a PER:CRY
heterodimer, which cannot bind to the CLOCK:BMAL1:E-box
(Fig. 7B). This conclusion may explain the severely disrupted
rhythm in PER2 overexpressing fibroblasts or mice (17), but is
counterintuitive to the genetically defined role of PER as a
repressor in the core clock circuitry, and calls for re-evaluation
of the core molecular clock model or revision of at least some
aspects of the model.
Quite conceivably, PER functions as a repressor of CLOCK:
BMAL1 not in the conventional sense by physical interaction
with the transactivator complex, but by participating in stabili-
zation and nuclear transport of CRY, which is the actual repres-
sor, as well as by regulating transcription through interactions
with some nuclear receptors as reported previously (42, 43)
(Fig. 7C). We note, however, that this model does not incorpo-
rate the well known and rather strong interactions of PER with
CLOCK and BMAL1. It is conceivable that PER interacts with
these proteins off DNA, and in doing so, prevents their associ-
ation with DNA although this is not consistent with the
reporter gene assay results that show that the PERprotein alone
is a weak inhibitor of CLOCK:BMAL1 activity. It is, however,
possible that PER, in addition to aiding CRY repressor function
in its capacity as chaperone. It may, to a limited degree, aid
in the formation of the CRY:CLOCK:BMAL1:E-box complex in
its capacity as amolecularmatchmaker by transient interaction
with CLOCK:BMAL1 on DNA. Clearly, additional work is
needed to clarify the mechanism by which PER participates in
the negative armof the transcription-translation feedback loop,
and, if there is some tissue specificity (such as the suprachias-
matic nucleus versus peripheral tissue) in the core clock
circuitry.
Enzymatic (Catalytic) Control of Circadian TTFL—It has
been shown that the core clock proteins are subject to phosphor-
ylation and ubiquitin-proteasome system-mediated degrada-
tion (1). In both Neurospora and Drosophila, the negative ele-
ments inhibit the DNA binding of the positive elements by
recruiting kinases to phosphorylate the positive elements (44,
45). Undoubtedly, these and other post-translational events
contribute significantly to the generation of a robust TTFLwith
circadian periodicity (21, 39, 46–48). Here, we have presented
some basic biochemical facts regarding the contributions of the
interactions of the proteins in the positive arm (CLOCK and
BMAL1) and negative arm (CRY and PER) of the clockwith one
another on and off DNA to the generation of the circadian
TTFL. We believe quantitative in vitro studies of the post-
translational modifications of clock proteins are needed for a
comprehensive description of the mammalian circadian clock.
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